Affiliation:
1. Mamak District Health Directorate, Ankara, Türkiye
Abstract
In modern healthcare services, patient safety is a primary goal. With technological advancements, the complexity of healthcare services increases, which in turn creates increased pressure on health professionals during decision-making processes and can lead to errors worldwide. Communication gaps, human factors, patient-originated issues, technical failures, and inadequate policies have been identified as the main causes of medical errors. While research shows that errors stem from human nature and are inevitable, it is emphasized that it is possible to develop methods that enhance patient safety. Utilizing digital technologies to improve the quality and efficiency of healthcare services is a crucial strategy. Innovations such as wearable technologies, mobile devices, digital media-delivered education and consulting services, telehealth applications, 3D printers, clinical decision support systems, and implantable biosensors encompass advancements in the digital health field. This research aims to analyze the complex and dynamic structure of healthcare services in the 21st century, especially considering the opportunities presented by the integration of artificial intelligence and genomic data, within the scope of the relevant literature.
Publisher
The European Research Journal
Reference58 articles.
1. 1. WHO. Patient safety curriculum guide: multi-professional edition. Switzerland. Available at: https://iris.who.int/bitstream/handle/10665/44641/9789241?sequence=3. Accessed 2011.
2. 2. WHO. Patient safety fact file. Patient Safety and Risk Management Service Delivery and Safety. Available at: https://www.who.int/news-room/photo-story/photo-story-detail/10-facts-on-patient-safety. Accessed August 26, 2019.
3. 3. WHO. Cancer. Available at: https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed February 3, 2022.
4. 4. Alemdar DK, Aktaş YY. Medical error types and causes made by nurses in Turkey. TAF Prev Med Bull. 2013;12(3):307-314. doi: 10.5455/pmb.1-1345816200.
5. 5. Blaus A, Madabushi R, Pacanowski M, et al. Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective. Circulation. 2015;132(15):1425-32. doi: 10.1161/CIRCULATIONAHA.114.009761.